Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models — Douglas Hanahan (1996) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
Shared by
Douglas Hanahan
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
Article
1996
en
Authors
+1 more
Douglas Hanahan
GC
Gerhard Christofori
PN
Paul Naik
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
Transgenic mouse models in angiogenesis and cardiovascular disease
Peter Carmeliet
,
D Collen
Article
2000
Transgenic mouse models in angiogenesis and cardiovascular disease
Peter Carmeliet
,
D�sir� Collen
Article
1998
Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis
Gabriele Bergers
,
Douglas Hanahan
,
Lisa M. Coussens
Article
2017
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
Cristina Belgiovine
,
Ezia Bello
,
Manuela Liguori
,
Ilaria Craparotta
,
Laura Mannarino
,
Lara Paracchini
,
Luca Beltrame
,
Sergio Marchini
,
Carlos M. Galmarini
,
Alberto Mantovani
,
Roberta Frapolli
,
Paola Allavena
,
Maurizio D’Incalci
Article
2024
Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
Dileep G. Nair
,
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.